Sandy Rollman Ovarian Cancer Foundation Company Profile

02:28 EST 20th November 2018 | BioPortfolio

The Sandy Rollman Ovarian Cancer Foundation, a 501 (c) (3) non-profit, now celebrating its 17th year, was created as a tribute to the life, character, and immense strength of Sandy Rollman. Sandy passed away from advanced ovarian cancer in May 2000. Prior to diagnosis, Sandy experienced many textbook symptoms. Her symptoms were whispering only no one was listening. The tragic result was that Sandy never had a chance against ovarian cancer.

News Articles [2878 Associated News Articles listed on BioPortfolio]

Sandy Rollman Ovarian Cancer Foundation and World Ovarian Cancer Coalition Partner to Host World Ovarian Cancer Day 2018 on May 8

World Ovarian Cancer Day Strives to Raise Awareness for Ovarian Cancer Today the Sandy Rollman Ovarian Cancer Foundation and the World Ovarian Cancer Foundation joined to cele...

Diagnosis of Ovarian Cancer Delayed by Woeful Lack of Awareness

Most comprehensive survey of women with ovarian cancer ever undertaken suggests raising awareness of the disease could improve outcomes for women A global study of wome...

5 Facts Every Woman Should Know About Ovarian Cancer

WEDNESDAY, Sept. 19, 2018 -- The early symptoms of ovarian cancer are often confused with less serious issues, making successful treatment less likely, a cancer expert warns. Ovarian cancer is called ...

Novel Targeted Agents Emerging in Ovarian Cancer

Diana P. English, MD, discusses the promise for ADCs in the landscape of ovarian cancer treatment and targeting p53 mutations in patients with ovarian cancer.

What Every Woman Needs to Know About Ovarian Cancer

SUNDAY, Sept. 2, 2018 -- Women need to know the symptoms of ovarian cancer and see a doctor if they have them, an ob-gyn expert says. Ovarian cancer is the fifth-leading cause of death in American wom...

Annual update of ovarian cancer statistics

A new report from the American Cancer Society provides an overview of ovarian cancer occurrence and mortality data. Ovarian Cancer Statistics, 2018 is published early online in CA: A Cancer Journal f...

Being diagnosed with ovarian cancer

Ovarian cancer is the 7th most common cancer in women world wide, and 5 year survival continues to remain low - in the UK this has been attributed to delayed diagnosis. In this podcast Sophie Cook ...

“Unusual” Mechanism Switches Off Ovarian Cancer Cells

NewsScientists have discovered a mechanism that deactivates ovarian cancer cells. The findings could lead to better treatments for women with ovarian cancer.

Drugs and Medications [875 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [6900 Associated PubMed Articles listed on BioPortfolio]

MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells.

Ovarian cancer is the most lethal malignancy of the women genital tract. Exploring novel factors involved in the development of ovarian cancer and characterizing the molecular mechanisms by which regu...

Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Aspirin use is associated with reduced risk of several cancers. A pooled analysis of 12 case-control studies showed a 10% decrease in ovarian cancer risk with regular aspirin use, which was stronger f...

Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer.

Ovarian cancer is usually treated with transurethral resection or systemic chemotherapy in clinic. However, the development of drug resistance in ovarian cancer is frequently observed in ovarian cance...

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Pelvic inflammatory disease (PID) has been associated with ovarian cancer risk. To clarify the role of Chlamydia trachomatis and other infectious agents in the development of ovarian cancer, we evalua...

The antitumor effects of entinostat in ovarian cancer require adaptive immunity.

Ovarian cancer is poorly immunogenic; however, increased major histocompatibility complex class II (MHCII) expression correlates with improved immune response and prolonged survival in patients with o...

Clinical Trials [9929 Associated Clinical Trials listed on BioPortfolio]

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Goals of this registry: 1.1 To collect and store very limited demographic information (age, birthdate, race and ethnicity), limited cancer risk and breast and ovarian disease history, as ...

The Effect of a Traditional Dietary Intervention on Diabetes Mellitus and Cardiovascular Disease Risk Factors in a First Nation Community: A Pilot Study

The purpose of this study is to evaluate whether or not a traditional First Nations diet (high protein) and/or a dietary intervention based upon current Canadian dietary recommendations (h...

Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire

To analyze the proportion of hereditary tumors in ovarian cancer patients in China, as well as the spectrum of variations; the ctDNA characteristics in patients with ovarian cancer; the co...

China Ovarian Cancer BRCA Testing Study

This is a prospective, multi-center, observational study, the primary objective is to evaluate the prevalence of gBRCA/sBRCAm in newly diagnosed ovarian cancer patients and explore ovarian...

Writing About Experiences With Ovarian Cancer

This online study aims to understand whether writing about one's experiences with ovarian cancer may be beneficial for psychological and physical wellbeing in women with a history of ovari...

Companies [2761 Associated Companies listed on BioPortfolio]

Sandy Rollman Ovarian Cancer Foundation

The Sandy Rollman Ovarian Cancer Foundation, a 501 (c) (3) non-profit, now celebrating its 17th year, was created as a tribute to the life, character, and immense strength ...

Ovarian Cancer Institute

The Ovarian Cancer Institute is a 501(c)(3) organization dedicated to ovarian cancer research. The work focuses on accurate diagnostics and improved therapeutics. Creators of a fi...

Avant Diagnostics, Inc.

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in large panel biomarker screening. Our first test, OvaDx®, developed in conjunction with Ar...

The Catherine Violet Hubbard Foundation

The Catherine Violet Hubbard Foundation, Inc. is a recognized 501(c)(3) organization. The Foundation was created to support charitable, scientific, literary or educational purpose...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes ...

More Information about "Sandy Rollman Ovarian Cancer Foundation" on BioPortfolio

We have published hundreds of Sandy Rollman Ovarian Cancer Foundation news stories on BioPortfolio along with dozens of Sandy Rollman Ovarian Cancer Foundation Clinical Trials and PubMed Articles about Sandy Rollman Ovarian Cancer Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sandy Rollman Ovarian Cancer Foundation Companies in our database. You can also find out about relevant Sandy Rollman Ovarian Cancer Foundation Drugs and Medications on this site too.

Quick Search


Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record